Personalis, Inc. (PSNL) 8-K Current Report: March 17, 2026
Filed: March 17, 2026
Health Care
Services-Medical LaboratoriesPersonalis, Inc. (PSNL) 8-K current report filed with SEC EDGAR on March 17, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
Personalis, Inc. 8-K Mar 17, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Richard Chen elevated to President effective March 13, 2026; CEO Hall gives up President title but retains CEO role
- • Chen is a deep company insider — joined as Chief Scientific Officer in 2011, co-founded Ingenuity Systems in 1997, Stanford MD/MS/BS
- • Base salary raised to $570,000 effective April 1, 2026; bonus target increased to 70% of base salary (~$399K target)
- • Equity grant: options on 37,500 shares (36-month monthly vest) plus 6,250 RSUs (bi-annual vest over 3 years)
- • Internal promotion signals stability and continuity in R&D leadership at a clinical genomics company
Other Personalis, Inc. 8-K Filings
Get deeper insights on Personalis, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.